Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Healing II: Complications

Healing II: Complications

Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Proteomic Profiling of Extracellular Vesicle-Enriched Plasma Using Mag-Net for Biomarker Discovery in Pancreatic Ductal Adenocarcinoma.

Journal of proteome research·2026

Same author

Efficacy and Safety of a Topical Skincare Regimen with Tripeptide/Hexapeptide following Aesthetic Procedures: Analysis of Two Randomized, Split-Face Trials in Asian Subjects.

Dermatology and therapy·2026

Same author

The Dermoepidermal Junction as the Initiation Point for Reversal of Dermatoporosis.

Journal of drugs in dermatology : JDD·2026

Same author

TriHex Technology and Reversal of Solar Elastosis: Dispelling Some Myths.

Journal of cosmetic dermatology·2026

Same author

Transitioning from Anti-aging to Skin Activation: Limiting Cellular Fatigue and Senescence for Skin Longevity.

Journal of drugs in dermatology : JDD·2026

Same author

Topical Peptide Technology and the Scarring Spectrum: Linking Mechanistic Pathways to Internal Scarring (Fibrous Banding) and External Scarring (Incisional) and Outcomes in Postsurgical Healing.

Aesthetic surgery journal. Open forum·2026

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay

Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay

Published on: April 28, 2022

Multimodality scar management program.

Alan D Widgerow¹, Laurence A Chait, Pieter J Stals

¹Plastic Surgery Department, University of the Witwatersrand, Witwatersrand, South Africa. surgeon@iafrica.com

Aesthetic Plastic Surgery

|December 3, 2008

Summary

This summary is machine-generated.

This study shows a multimodality scar management approach significantly improves hypertrophic scar outcomes. The treatment effectively controls inflammation and enhances scar hydration for better results.

More Related Videos

In Vitro Model of Human Cutaneous Hypertrophic Scarring using Macromolecular Crowding

In Vitro Model of Human Cutaneous Hypertrophic Scarring using Macromolecular Crowding

Published on: May 1, 2020

A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring

A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring

Published on: November 29, 2024

Related Experiment Videos

Last Updated: Jun 27, 2026

Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay

Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay

Published on: April 28, 2022

In Vitro Model of Human Cutaneous Hypertrophic Scarring using Macromolecular Crowding

In Vitro Model of Human Cutaneous Hypertrophic Scarring using Macromolecular Crowding

Published on: May 1, 2020

A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring

A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring

Published on: November 29, 2024

Area of Science:

Dermatology
Plastic Surgery
Wound Healing

Background:

Previous research informed a multimodality scar prevention regime.
This study incorporated active agents to manage inflammation and improve scar hydration.
Key targets included scar tension, hydration, collagen maturation, and inflammation control.

Purpose of the Study:

To evaluate the efficacy of a novel multimodality management regimen for hypertrophic scar prevention.
To assess the impact of targeted interventions on scar characteristics.

Main Methods:

A combination of agents in an occlusive dressing was applied to surgical scars.
170 scars across 120 patients were stratified into four treatment and control groups.
Scar assessments utilized Vancouver, Manchester, morphologic, and Patient and Observer Scar Assessment techniques at 1, 2, and 6 months.

Main Results:

Treated scars demonstrated improved outcomes across all assessment variations.
Patient and observer assessments showed strong correlation.
Statistically significant positive scar outcomes were observed in treatment groups at 6 months.

Conclusions:

The multimodality approach to scar control yielded significant benefits.
This regimen is effective in improving hypertrophic scar appearance and patient outcomes.
The study confirms the value of a comprehensive strategy for scar management.